Hartwig Medical Foundation Australia

Hartwig Medical Foundation Australia is a data- and software-driven not-for-profit organization, dedicated to advancing cancer genomics. Established in 2016, Hartwig’s mission is to build and improve software for molecular diagnostics and treatment/trial matching for today’s patient and support a learning healthcare system for future patients through database functionality (storage, reuse, access, connectivity, visualization).

Building on the development of Hartwig’s core open-source bioinformatics tools (2018–2022), Hartwig Australia continues to advance this mission. In 2023–2024, this was further supported by the launch of OncoAnalyser, a comprehensive analysis pipeline, and expansion to support large panels.

Organization

Hartwig Medical Australia operates in close collaboration with Hartwig Medical Netherlands as a non-profit limited liability company guided by a multidisciplinary team of experts in genomics, informatics, and business development. Our structure supports innovation, collaboration, and clinical integration without listing individual names. 

Partners

We collaborate with leading institutions and initiatives, including: 

• Peter MacCallum Cancer Centre 
• University of Melbourne Centre for Cancer Research (UMCCR) 
• Children’s Cancer Institute Australia (CCIA) 
• OMICO 

and other national and international stakeholders. 

People

Directors
Peter Priestly (Managing Director), Iain Gentle, Brian Hitchcock, Rob Defares

Molecular Analysis
Charles Shale, Thomas Garrety, Luan Nguyen, Reece Jones, Tim Lavers, Matthew Cooper

Clinical Informatics
Hong Wing Lee, Junran Cao

Business Development
Hans van Snellenberg, Nicole Schonrock

Achievements

• Creation of OncoAnalyser, a fully automated, scalable pipeline for molecular analysis and reporting.
• Flexible, platform-agnostic tools supporting WGS, large panels, and multimodal inputs (DNA, RNA, ctDNA).
• Clinical adoption of OncoAnalyser and participation in international pediatric data federation projects.
• Co development of a heamatological Panel used in standard of care for 10.000 patient per year
• Open-source contributions to the global genomics community via GitHub and nf-core.. 

Plans

Looking ahead, Hartwig Medical Australia aims to: 

• Launch Software as a Service (SaaS) for OncoAnalyser by mid-2026, enabling cloud-based, automated molecular analysis and reporting. 
• Expand OncoAnalyser usage to multiple 
  clinical laboratories. 
• Develop and validate low-cost,
  open-source panels for heamatological and solid tumors. 

Careers

Hartwig Medical Foundation Australia is a small team of highly skilled software engineers and data scientists with expertise in all aspects of bioinformatics. They are looking for colleagues. 

Contact

Hartwig Medical Foundation Australia 
Address: 141 Walker street (213 Miller Street per 1/3/2026), North Sydney, 2060 NSW